XML 63 R45.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENTS AND CONCENTRATIONS (Tables)
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT NET REVENUES

Segment net revenues, segment operating expenses and segment contribution information consisted of the following:

  

   Branded   ImprimisRx   Consolidated 
   Year Ended December 31, 2024 
   Branded   ImprimisRx   Consolidated 
Product sales, net  $115,120,000   $83,499,000   $198,619,000 
Other revenues   995,000    -    995,000 
Total revenues   116,115,000    83,499,000    199,614,000 
Cost of sales   (21,667,000)   (27,578,000)   (49,245,000)
Gross profit   94,448,000    55,921,000    150,369,000 
Operating expenses:               
Selling, general and administrative   62,301,000    23,607,000    85,908,000 
Research and development   2,890,000    386,000    3,276,000 
Segment contribution  $29,257,000   $31,928,000    61,185,000 
Corporate             43,409,000 
Research and development             8,954,000 
Income from operations            $8,822,000 

 

   Branded   ImprimisRx   Consolidated 
   Year Ended December 31, 2023 
   Branded   ImprimisRx   Consolidated 
Product sales, net  $37,512,000   $79,935,000   $117,447,000 
Other revenues   12,746,000    -    12,746,000 
Total revenues   50,258,000    79,935,000    130,193,000 
Cost of sales   (12,662,000)   (26,978,000)   (39,640,000)
Gross profit   37,596,000    52,957,000    90,553,000 
Operating expenses:               
Selling, general and administrative   18,126,000    29,210,000    47,336,000 
Research and development   641,000    966,000    1,607,000 
Segment contribution  $18,829,000   $22,781,000    41,610,000 
Corporate             36,134,000 
Research and development             5,045,000 
Income from operations            $431,000 
SCHEDULE OF REVENUES BY SEGMENT

Revenues by segment are further described as follows:

 

   For the Years Ended 
   December 31, 
   2024   %   2023   % 
IHEEZO  $49,303,000    25%  $20,621,000    16%
VEVYE   28,061,000    14%   1,766,000    1%
Other branded products   37,836,000    19%   15,125,000    12%
Other revenue, net   915,000    0%   12,746,000    10%
Branded revenue, net   116,115,000    58%   50,258,000    39%
ImprimisRx revenue, net   83,499,000    42%   79,935,000    61%
Total revenues, net  $199,614,000    100%  $130,193,000    100%